Retarding Novikoff tumor growth by altering host rat cholesterol metabolism

Philip D Schneider, Eve K. Chan, Ignacio J. Guzman, Richard D. Rucker, Richard L. Varco, Henry Buchwald

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Tumor cells, in vitro, must derive the majority of their required cholesterol from their host milieu. To determine if limiting tumor-available cholesterol results in limited tumor growth in vivo, Holtzman rats were given 10 × 106 Novikoff ascites tumor cells subcutaneously. Prior to inoculation, animals received either distal small bowel exclusion or sham operation plus either standard chow or estrone-containing chow (0.0025% or 0.01%) diets. In three separate experiments it was shown that (1) tumor weight was positively correlated with whole plasma cholesterol levels (r = 0.495; P < 0.05); (2) the lowest tumor weights were correlated with the lowest plasma cholesterol; (3) low density and very low density lipoprotein cholesterol levels were both individually and in combination positively correlated with tumor weight (2R = 0.828; P < 0.01); and (4) survival of subcutaneous tumor inoculated animals was significantly greater in those animals shown to have the lowest plasma cholesterol, 27 ± 1 days versus 29 ± 1 days; (P < 0.05). These data support the concept that limiting tumor-available cholesterol by altering host cholesterol metabolism will limit tumor growth.

Original languageEnglish (US)
Pages (from-to)409-416
Number of pages8
JournalSurgery
Volume87
Issue number4
StatePublished - 1980
Externally publishedYes

Fingerprint

Cholesterol
Growth
Tumor Burden
Neoplasms
VLDL Cholesterol
Estrone
Ascites
Sprague Dawley Rats
Diet

ASJC Scopus subject areas

  • Surgery

Cite this

Schneider, P. D., Chan, E. K., Guzman, I. J., Rucker, R. D., Varco, R. L., & Buchwald, H. (1980). Retarding Novikoff tumor growth by altering host rat cholesterol metabolism. Surgery, 87(4), 409-416.

Retarding Novikoff tumor growth by altering host rat cholesterol metabolism. / Schneider, Philip D; Chan, Eve K.; Guzman, Ignacio J.; Rucker, Richard D.; Varco, Richard L.; Buchwald, Henry.

In: Surgery, Vol. 87, No. 4, 1980, p. 409-416.

Research output: Contribution to journalArticle

Schneider, PD, Chan, EK, Guzman, IJ, Rucker, RD, Varco, RL & Buchwald, H 1980, 'Retarding Novikoff tumor growth by altering host rat cholesterol metabolism', Surgery, vol. 87, no. 4, pp. 409-416.
Schneider PD, Chan EK, Guzman IJ, Rucker RD, Varco RL, Buchwald H. Retarding Novikoff tumor growth by altering host rat cholesterol metabolism. Surgery. 1980;87(4):409-416.
Schneider, Philip D ; Chan, Eve K. ; Guzman, Ignacio J. ; Rucker, Richard D. ; Varco, Richard L. ; Buchwald, Henry. / Retarding Novikoff tumor growth by altering host rat cholesterol metabolism. In: Surgery. 1980 ; Vol. 87, No. 4. pp. 409-416.
@article{058a098c93ae49fb9b63607cb7a421f3,
title = "Retarding Novikoff tumor growth by altering host rat cholesterol metabolism",
abstract = "Tumor cells, in vitro, must derive the majority of their required cholesterol from their host milieu. To determine if limiting tumor-available cholesterol results in limited tumor growth in vivo, Holtzman rats were given 10 × 106 Novikoff ascites tumor cells subcutaneously. Prior to inoculation, animals received either distal small bowel exclusion or sham operation plus either standard chow or estrone-containing chow (0.0025{\%} or 0.01{\%}) diets. In three separate experiments it was shown that (1) tumor weight was positively correlated with whole plasma cholesterol levels (r = 0.495; P < 0.05); (2) the lowest tumor weights were correlated with the lowest plasma cholesterol; (3) low density and very low density lipoprotein cholesterol levels were both individually and in combination positively correlated with tumor weight (2R = 0.828; P < 0.01); and (4) survival of subcutaneous tumor inoculated animals was significantly greater in those animals shown to have the lowest plasma cholesterol, 27 ± 1 days versus 29 ± 1 days; (P < 0.05). These data support the concept that limiting tumor-available cholesterol by altering host cholesterol metabolism will limit tumor growth.",
author = "Schneider, {Philip D} and Chan, {Eve K.} and Guzman, {Ignacio J.} and Rucker, {Richard D.} and Varco, {Richard L.} and Henry Buchwald",
year = "1980",
language = "English (US)",
volume = "87",
pages = "409--416",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Retarding Novikoff tumor growth by altering host rat cholesterol metabolism

AU - Schneider, Philip D

AU - Chan, Eve K.

AU - Guzman, Ignacio J.

AU - Rucker, Richard D.

AU - Varco, Richard L.

AU - Buchwald, Henry

PY - 1980

Y1 - 1980

N2 - Tumor cells, in vitro, must derive the majority of their required cholesterol from their host milieu. To determine if limiting tumor-available cholesterol results in limited tumor growth in vivo, Holtzman rats were given 10 × 106 Novikoff ascites tumor cells subcutaneously. Prior to inoculation, animals received either distal small bowel exclusion or sham operation plus either standard chow or estrone-containing chow (0.0025% or 0.01%) diets. In three separate experiments it was shown that (1) tumor weight was positively correlated with whole plasma cholesterol levels (r = 0.495; P < 0.05); (2) the lowest tumor weights were correlated with the lowest plasma cholesterol; (3) low density and very low density lipoprotein cholesterol levels were both individually and in combination positively correlated with tumor weight (2R = 0.828; P < 0.01); and (4) survival of subcutaneous tumor inoculated animals was significantly greater in those animals shown to have the lowest plasma cholesterol, 27 ± 1 days versus 29 ± 1 days; (P < 0.05). These data support the concept that limiting tumor-available cholesterol by altering host cholesterol metabolism will limit tumor growth.

AB - Tumor cells, in vitro, must derive the majority of their required cholesterol from their host milieu. To determine if limiting tumor-available cholesterol results in limited tumor growth in vivo, Holtzman rats were given 10 × 106 Novikoff ascites tumor cells subcutaneously. Prior to inoculation, animals received either distal small bowel exclusion or sham operation plus either standard chow or estrone-containing chow (0.0025% or 0.01%) diets. In three separate experiments it was shown that (1) tumor weight was positively correlated with whole plasma cholesterol levels (r = 0.495; P < 0.05); (2) the lowest tumor weights were correlated with the lowest plasma cholesterol; (3) low density and very low density lipoprotein cholesterol levels were both individually and in combination positively correlated with tumor weight (2R = 0.828; P < 0.01); and (4) survival of subcutaneous tumor inoculated animals was significantly greater in those animals shown to have the lowest plasma cholesterol, 27 ± 1 days versus 29 ± 1 days; (P < 0.05). These data support the concept that limiting tumor-available cholesterol by altering host cholesterol metabolism will limit tumor growth.

UR - http://www.scopus.com/inward/record.url?scp=0018895735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018895735&partnerID=8YFLogxK

M3 - Article

C2 - 7368085

AN - SCOPUS:0018895735

VL - 87

SP - 409

EP - 416

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 4

ER -